Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

James van Geelen, founder of Citrini Research, is focused on the next stage of AI, surrounding humanoid robots.

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

A popular weight-loss jab has been approved to treat a common sleep disorder in Australia, after a new ruling by the medicine ...

Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous positive airway ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

CI Insights From Zepbound to AD109, pharma innovation is reshaping Obstructive Sleep Apnea. Discover key players, C ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.